Hydrocortisone has a protective effect on CyclosporinA-induced cardiotoxicity

Journal of Cellular Physiology

Volumn 195, Issue 1, 2003, Pages 21-26

  Florio, Salvatore ^a   Ciarcia, Roberto ^a   Crispino, Luca ^a   Pagnini, Ugo ^a   Ruocco, Antonio ^a   Kumar, Christine ^b   D'Andrilli, Giuseppina ^b   Russo, Ferdinando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HYDROCORTISONE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE CELL; INHIBITION KINETICS; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSPORT KINETICS;

ANIMALS; CALCIUM; CELLS, CULTURED; CYCLOSPORINE; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYOCYTES, CARDIAC; NITRIC OXIDE; OXIDATIVE STRESS; RATS;

EID: 0037375726     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10216     Document Type: Article

References (41)

1. Andoh TF, Bennett WM. 1998. Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 7:265-270.
2. Banijamali HS, ter Keurs MH, Paul LC, ter Keurs HE. 1993. Excitation-contration coupling in rat heart: Influence of ciclospor-inA. Cardiovasc Res 27:1845-1854.
3. Braun S, Sarkozi E, Mc Ferrin J, Askanas V. 1995. Hydrocortisone influences voltage-dependent L-type calcium channel in cultured human skeletal muscle. J Neurosci Res 41:727-733.
4. Chandler LJ, Kopniscky K, Richards E, Crews FT, Summers C. 1995. Angiotensin II decreases inducible nitric oxide synthase expression in rat astroglial cultures. Am J Physiol 268:C700-C707.
5. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. De Nicola L, Thomson SC, Wead LM, Brown MR. 1993. Arginine feending modifies cyclosporine nephrotoxicity in rats. J Clin Invest 92:822-827.
7. Doolan CM, O'Sullivan GC, Harvey BJ. 1998. Rapid effects of corticosteroids on cytosolic protein kinase C intracellular calcium concentration in human distal colon. Mol Cell Endocrinol 138:71-79.
8. Ebisawa T, Kondo I, Masaki E, Hori S, Kawamura M. 2000. Capacitative calcium entry is involved in steroidogenesis in bovine adrenocortical fascicolata cells. J Endocrinol 167:473-478.
9. Edwards BD, Chalmers RJ, O'Driscoll JB, Mitchell DM, Smith RJ, Lawson RS, Testa HJ, Ballardie FW. 1994. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis. Clin Nephrol 41:350-356.
10. Esterbauer H, Cheeseman KH. 1990. Determination of aldhehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods enzymol 186:407-421.
11. Fogo A, Hellings SE, Inagami T, Kon V. 1992. Endothelin receptors antagonism in protective in vivo acute cyclosporin toxicity. Kidney Int 42:770-774.
12. Frapier JM, Choby C, Mangoni ME, Nargeot J, Albat B, Richard S. 2001. CyclosporinA increases basal intracellular calcium and calcium responses to endothelin and vasopressin in human coronary myocytes. FEBS Lett 493:57-62.
13. Goldberg HJ, Wong PY, Cole EH, Levy GA, Skorecki KL. 1989. Dissociation between the immunosuppressive activity of cyclosporin derivatives and their effects on intracellular calcium signalling in mesangial cells. Transplantation 47:731-733.
14. 2+ indicators with greatly improved fuorescence properties. J Biol Chem 260:3440-3450.
15. Jourd'heuil D, Kang D, Gtisham MB. 1997. Interaction between superoxide and nitric oxide: Implication in DNA damage and muthagenesis. Front Biosci 2:189-196.
16. Kelly JJ, Tam SH, Williamson PM, Lawson PM, Lawson J, Whitworth JA. 1998. The nitric oxide system and cortisol-induced hypertension in human. Clin Exp Pharmacol Physiol 25:945-946.
17. Kingma I, Harmsen E, ter Keurs HEDI, Benediktsson H, Paul LC. 1991. Cyclosporine-associated reduction in systolic myocardial function in rat. Int J Cardiol 31:15-22.
18. Knonickova E, Kamenickova L, Hynie S, Farghali H. 2000. CiclosporinA modifies cytoplasmic calcium levels in isolated hepatocytes exposed to oxidative stress due to tert-butylhydroperoxide. Physiol Res 49:471-474.
19. Lo Russo A, Passaquin AC, Andre P, Skutella M, Ruegg UT. 1996. Effect of cyclosporinA and analogues on cytosolic calcium and vasoconstrition: Possible lack of relationship to immunosuppressive activity. Br J Pharmacol 118:885-892.
20. Longoni B, Giovannini L, Migliori M, Bertelli AA, Bertelli A. 1999. Cyclosporine-induced lipid peroxidation and propionyl carnitine protective effect. Int J Tissue React 21:7-11.
21. Lowry OH, Rosembrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
22. Lu C, Chan SL, Haughey N, Lee WT, Mattson MP. 2001. Selective and biphasic effect of the membrane lipid peroxidation product 4-hydroxy-2-3-nonenal on N-methyl-D-aspartate channels. J Neurochem 78:577-589.
23. Mervaala EMA, Pere AK, Lindgren L, Laasko J, Teräväinen TL, Karjala K, Vapaatalo J, Ahonen J, Karppanen H. 1997. Effects of dietary sodium and magnesium on ciclosporineA-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. Hypertension 29:822-827.
24. Navarro-Antolin J, Hernandez-Pereira O, Lopez-Ongil S, Rodriguez-Puyol M, Lamas S. 1998. CsA and FK-506 up-regulate eNOS expression: Role of reactive oxigen species and AP-1. Kidney Int 68(Suppl):S20-S24.
25. Otamiri T. 1989. Oxigen radicals, lipid peroxidation and neutrophil infiltration after small-intestinal ischemia and reperfusion. Surgery 105:593-597.
26. Pacilio C, Florio S, Pagnini U, Crispino A, Claudio PP, Pacilio G, Pagnini G. 1998. Modification of membrane fluidity and depolarization by some anthracyclines on different cell lines. Interference by medroxyprogesterone acetate and verapamil. Anticancer Res 18:4027-4034.
27. Pagnini U, Florio S, Crispino L, Pagnini G, Colangelo D, Rocco D, Pacilio C, Pacilio M, Macaluso M, Giordano A. 2002. Direct effect of a gonadotropin-releasing hormone agonist on the growth of canine mammary tumour cells. J Cell Biochem 85:470-481.
28. Pagnini U, Pacilio C, Florio S, Crispino A, Claudio PP, Giordano A, Pagnini G. 2000a. Medroxyprogesterone acetate increases anthracyclynes uptake in chronic limphatic leukaemia cells: Role of nitric oxide and lipid peroxidation. Anticancer Res 20:33-42.
29. Pagnini U, Florio S, Lombardi P, d'Angelo D, Avallone L, Galdiero M, Iovane G, Tortora G, Pagnini G. 2000b. Modulation of anthracycline activity in canine mammary tumour cells in vitro by medroxyprogesterone acetate. Res Vet Sci 69:255-262.
30. Paul LC. 1989. Maintenance of immunosuppression: Cyclosporin. Contemp Issue Nephrol 19:105-128.
31. Sansom J, Neumann W, Schultz-Neumann A, Clerc B, Jegou JP, de Haas V, Weingarten A. 1995. Treatment of keratoconjuntivitis sicca in dogs with cyclosporine ophtalmic ointment: A European clinical field trial. Vet Rec 137:504-507.
32. Sevavian A, Shen L, Ursini F. 2000. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropiridine calcium antagonist. Pharm Res 17:999-1006.
33. Stephan D, Billing A, Krieger JP, Grima M, Hofner M, Imbs JL, Barthelmembs M. 1995. Endothelium-dependent relaxation in the isolated rat kidney: Impairment by CyclosporineA. J Cardiovasc Pharm 26:859-868.
34. Taler SJ, Textor SC, Canzanello VJ, Schwartz L. 1999. Cyclosporin-induced hypertension: Incidence, pathogenesis an management. Drug Saf 20:437-449.
35. Tao XB, Li WH, Huang N, Tan YX, Yuan M, Zhou B. 1997. Effects of calcium inhibitor on hydrogen peroxide-induced damage and calcium influx in bovine aortic endothelial cells in culture. Yao Xue Xue Bao 32:485-489.
36. Tolstuckima TI, Rakitskaia VV, Flerov MA. 1999. Lipid peroxidation in the rat hyppocampus after cortisol administration under stress conditions. Ross Fiziol Zh Im IM Sekenova 85:436-441.
37. Vaden SL, Breitschwerdt EB, Armstrong PJ, Correa MT, Brown C, Polzin DJ, Brace JJ, Di Bartola SP, Barsanti JA, Crowell W. 1995. The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis. J Vet Intern Med 9:259-266.
38. Vasquez-Viver J, Martasek P, Hogg N, Masters BS, Pritchard KA, Jr, Kalayanaraman B. 1997. Endhothelial nitric oxide synthases-dependent superoxide generation from adriamicin. Biochemistry 36:11293-11297.
39. Wang C, Salahudden AK. 1994. Ciclosporine nephrotoxicity attenuation by antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 58:940-946.
40. Watson CL, Few WIII, Panol G, Jackson DC. 1994. Lactate acidosis transiently increases metabolic rate of turtle myocytes. Am J Physiol 35:R1238-R1253.
41. Zhong Z, Arteel GE, Connor HD, Yin M, Frankemberg MV, Stachelwitz RF, Raleigh JA, Mason RP, Thurman RG. 1998. CyclosporinA increases hypoxia and free radical production in rat kidney: Prevention by diteary glycine. Am J Physio 1275:595-604.